Jay Shepard
Director · Esperion Therapeutics, Inc.
Individual
- 2025
- Jul 13, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jay Shepard files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Alexander J. Denner - $20.53M in IRWD purchases and sales in the last 12 months
- Ronald Silver - $831K in IRWD purchases and sales in the last 12 months
- Thomas A. McCourt - $740K in IRWD purchases and sales in the last 12 months
- Sheldon L. Koenig - $239K in ESPR purchases and sales in the last 12 months
- Minardo John - $136K in IRWD purchases and sales in the last 12 months
- Michael Shetzline - $122K in IRWD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jay Shepard?
Jay Shepard is a corporate insider, tracked as Director of Esperion Therapeutics, Inc. (ESPR). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Jay Shepard last file a Form 4?
The most recent primary Form 4 on record is dated 13 July 2026, one of 5 filings going back to 2025.
